Modeling of C/EBPα Mutant Acute Myeloid Leukemia Reveals a Common Expression Signature of Committed Myeloid Leukemia-Initiating Cells

Cancer Cell

Volumn 13, Issue 4, 2008, Pages 299-310

  Kirstetter, Peggy ^a   Schuster, Mikkel B ^a,b   Bereshchenko, Oksana ^a   Moore, Susan ^a   Dvinge, Heidi ^c   Kurz, Elke ^a   Theilgaard Mönch, Kim ^b   Månsson, Robert ^d   Pedersen, Thomas Å ^a   Pabst, Thomas ^e   Schrock, Evelin ^f   Porse, Bo T ^b   Jacobsen, Sten Eirik W ^d   Bertone, Paul ^c   Tenen, Daniel G ^g   Nerlov, Claus ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^b Mental Health Services CPH   (Denmark)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d LUND UNIVERSITY   (Sweden)

^e UNIVERSITY OF BERN   (Switzerland)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^g HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

CELLCYCLE

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; MIXED LINEAGE LEUKEMIA PROTEIN; PROTEIN P30; PROTEIN P42; CD11B ANTIGEN; ISOPROTEIN; MUTANT PROTEIN; STEM CELL FACTOR RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA MODIFICATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE LOCUS; GENE LOSS; GENE MUTATION; GENETIC MODEL; GRANULOCYTE; LEUKEMIA CELL; LEUKEMOGENESIS; MACROPHAGE; MALE; MOLECULAR MIMICRY; MOUSE; MYELOID LEUKEMIA; MYELOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; ANIMAL; BIOLOGICAL MODEL; CANCER STEM CELL; CANCER TRANSPLANTATION; CELL DIFFERENTIATION; CYTOLOGY; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE MUTANT; MYELOMONOCYTIC LEUKEMIA; PATHOLOGY; PHENOTYPE;

MUS;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIFFERENTIATION; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GRANULOCYTES; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MACROPHAGE-1 ANTIGEN; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MUTANT PROTEINS; MYELOID PROGENITOR CELLS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; PHENOTYPE; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 41249103144     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2008.02.008     Document Type: Article

References (36)

1. Ayton P.M., and Cleary M.L. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev. 17 (2003) 2298-2307
2. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3 (1997) 730-737
3. Cozzio A., Passegue E., Ayton P.M., Karsunky H., Cleary M.L., and Weissman I.L. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 17 (2003) 3029-3035
4. Frohling S., Schlenk R.F., Stolze I., Bihlmayr J., Benner A., Kreitmeier S., Tobis K., Dohner H., and Dohner K. CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations. J. Clin. Oncol. 22 (2004) 624-633
5. Heath V., Suh H.C., Holman M., Renn K., Gooya J.M., Parkin S., Klarmann K.D., Ortiz M., Johnson P., and Keller J. C/EBPα deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo. Blood 104 (2004) 1639-1647
6. Huntly B.J., Shigematsu H., Deguchi K., Lee B.H., Mizuno S., Duclos N., Rowan R., Amaral S., Curley D., Williams I.R., et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 6 (2004) 587-596
7. Johansen L.M., Iwama A., Lodie T.A., Sasaki K., Felsher D.W., Golub T.R., and Tenen D.G. c-Myc is a critical target for C/EBPα in granulopoiesis. Mol. Cell. Biol. 21 (2001) 3789-3806
8. Kirstetter P., Anderson K., Porse B.T., Jacobsen S.E., and Nerlov C. Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nat. Immunol. 7 (2006) 1048-1056
9. Kjeldsen L., Koch C., Arnljots K., and Borregaard N. Characterization of two ELISAs for NGAL, a newly described lipocalin in human neutrophils. J. Immunol. Methods 198 (1996) 155-164
10. Kottaridis P.D., Gale R.E., Langabeer S.E., Frew M.E., Bowen D.T., and Linch D.C. Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors. Blood 100 (2002) 2393-2398
11. Krivtsov A.V., Twomey D., Feng Z., Stubbs M.C., Wang Y., Faber J., Levine J.E., Wang J., Hahn W.C., Gilliland D.G., et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442 (2006) 818-822
12. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., and Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367 (1994) 645-648
13. Leroy H., Roumier C., Huyghe P., Biggio V., Fenaux P., and Preudhomme C. CEBPA point mutations in hematological malignancies. Leukemia 19 (2005) 329-334
14. Lin F.T., MacDougald O.A., Diehl A.M., and Lane M.D. A 30-kDa alternative translation product of the CCAAT/enhancer binding protein α message: transcriptional activator lacking antimitotic activity. Proc. Natl. Acad. Sci. USA 90 (1993) 9606-9610
15. Lin L.I., Chen C.Y., Lin D.T., Tsay W., Tang J.L., Yeh Y.C., Shen H.L., Su F.H., Yao M., Huang S.Y., et al. Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells. Clin. Cancer Res. 11 (2005) 1372-1379
16. Monaco G., Konopleva M., Munsell M., Leysath C., Wang R.Y., Jackson C.E., Korbling M., Estey E., Belmont J., and Andreeff M. Engraftment of acute myeloid leukemia in NOD/SCID mice is independent of CXCR4 and predicts poor patient survival. Stem Cells 22 (2004) 188-201
17. Nerlov C. C/EBPα mutations in acute myeloid leukaemias. Nat. Rev. Cancer 4 (2004) 394-400
18. Pabst T., Mueller B.U., Zhang P., Radomska H.S., Narravula S., Schnittger S., Behre G., Hiddemann W., and Tenen D.G. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia. Nat. Genet. 27 (2001) 263-270
19. Pearce D.J., Taussig D., Zibara K., Smith L.L., Ridler C.M., Preudhomme C., Young B.D., Rohatiner A.Z., Lister T.A., and Bonnet D. AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML. Blood 107 (2006) 1166-1173
20. Porse B.T., Pedersen T.A., Xu X., Lindberg B., Wewer U.M., Friis-Hansen L., and Nerlov C. E2F repression by C/EBPα is required for adipogenesis and granulopoiesis in vivo. Cell 107 (2001) 247-258
21. Porse B.T., Bryder D., Theilgaard-Monch K., Hasemann M.S., Anderson K., Damgaard I., Jacobsen S.E., and Nerlov C. Loss of C/EBPα cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage. J. Exp. Med. 202 (2005) 85-96
22. Schrock E., du Manoir S., Veldman T., Schoell B., Wienberg J., Ferguson-Smith M.A., Ning Y., Ledbetter D.H., Bar-Am I., Soenksen D., Garini Y., et al. Multicolor spectral karyotyping of human chromosomes. Science 273 (1996) 494-497
23. Sellick G.S., Spendlove H.E., Catovsky D., Pritchard-Jones K., and Houlston R.S. Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia. Leukemia 19 (2005) 1276-1278
24. Shih L.Y., Huang C.F., Wu J.H., Lin T.L., Dunn P., Wang P.N., Kuo M.C., Lai C.L., and Hsu H.C. Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse. Blood 100 (2002) 2387-2392
25. Shih L.Y., Liang D.C., Huang C.F., Wu J.H., Lin T.L., Wang P.N., Dunn P., Kuo M.C., and Tang T.C. AML patients with CEBPα mutations mostly retain identical mutant patterns but frequently change in allelic distribution at relapse: a comparative analysis on paired diagnosis and relapse samples. Leukemia 20 (2006) 604-609
26. Smith M.L., Cavenagh J.D., Lister T.A., and Fitzgibbon J. Mutation of CEBPA in familial acute myeloid leukemia. N. Engl. J. Med. 351 (2004) 2403-2407
27. Somervaille T.C., and Cleary M.L. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 10 (2006) 257-268
28. Steidl U., Rosenbauer F., Verhaak R.G., Gu X., Ebralidze A., Otu H.H., Klippel S., Steidl C., Bruns I., Costa D.B., et al. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells. Nat. Genet. 38 (2006) 1269-1277
29. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102 (2005) 15545-15550
30. Tiesmeier J., Czwalinna A., Muller-Tidow C., Krauter J., Serve H., Heil G., Ganser A., and Verbeek W. Evidence for allelic evolution of C/EBPα mutations in acute myeloid leukaemia. Br. J. Haematol. 123 (2003) 413-419
31. Wagner K., Zhang P., Rosenbauer F., Drescher B., Kobayashi S., Radomska H.S., Kutok J.L., Gilliland D.G., Krauter J., and Tenen D.G. Absence of the transcription factor CCAAT enhancer binding protein α results in loss of myeloid identity in bcr/abl-induced malignancy. Proc. Natl. Acad. Sci. USA 103 (2006) 6338-6343
32. Wang N.D., Finegold M.J., Bradley A., Ou C.N., Abdelsayed S.V., Wilde M.D., Taylor L.R., Wilson D.R., and Darlington G.J. Impaired energy homeostasis in C/EBPα knockout mice. Science 269 (1995) 1108-1112
33. Wiktor A., Rybicki B.A., Piao Z.S., Shurafa M., Barthel B., Maeda K., and Van Dyke D.L. Clinical significance of Y chromosome loss in hematologic disease. Genes Chromosomes Cancer 27 (2000) 11-16
34. Wong P., Iwasaki M., Somervaille T.C., So C.W., and Cleary M.L. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes Dev. 21 (2007) 2762-2774
35. Zhang D.E., Zhang P., Wang N.D., Hetherington C.J., Darlington G.J., and Tenen D.G. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice. Proc. Natl. Acad. Sci. USA 94 (1997) 569-574
36. Zhang P., Iwasaki-Arai J., Iwasaki H., Fenyus M.L., Dayaram T., Owens B.M., Shigematsu H., Levantini E., Huettner C.S., Lekstrom-Himes J.A., et al. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBPα. Immunity 21 (2004) 853-863